Shock efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death: Initial multicenter experience

Circulation: Arrhythmia and Electrophysiology

Volumn 5, Issue 5, 2012, Pages 913-919

  Aydin, Ali ^a   Hartel, Friederike ^a   Schlüter, Michael ^a   Butter, Christian ^b   Köbe, Julia ^c   Seifert, Martin ^b   Gosau, Nils ^a   Hoffmann, Boris ^a   Hoffmann, Matthias ^a   Vettorazzi, Eik ^d   Wilke, Iris ^a   Wegscheider, Karl ^d   Reichenspurner, Hermann ^a   Eckardt, Lars ^c   Steven, Daniel ^a   Willems, Stephan ^a  

^a UNIVERSITY HEART CENTER HAMBURG   (Germany)

^b Department of Cardiology   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Defibrillation threshold; Implantable cardioverter defibrillator; Implantable cardioverter defibrillator shock failure; Subcutaneous implantable cardioverter defibrillator; Ventricular tachyarrhythmia

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONVULSIVE THERAPY; DEFIBRILLATION; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INTRAOPERATIVE PERIOD; MALE; MULTICENTER STUDY; MYOCARDITIS; OUTCOME ASSESSMENT; POLYMORPHIC VENTRICULAR TACHYCARDIA; PRIMARY PREVENTION; PRIORITY JOURNAL; RESUSCITATION; SECONDARY PREVENTION; SINUS RHYTHM; SINUS TACHYCARDIA; SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; SUDDEN DEATH; CLINICAL TRIAL; ECHOCARDIOGRAPHY; GERMANY; HEART STROKE VOLUME; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PATIENT SELECTION; STATISTICAL MODEL; TREATMENT OUTCOME;

ADULT; AGED; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PATIENT SELECTION; PRIMARY PREVENTION; SECONDARY PREVENTION; STROKE VOLUME; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 84872014642     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.112.973339     Document Type: Article

References (18)

1. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008;117:e350-e408.
2. Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, Weisse U, Seidl K. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation. 2007;115:2474-2480.
3. Ellenbogen KA, Wood MA, Shepard RK, Clemo HF, Vaughn T, Holloman K, Dow M, Leffler J, Abeyratne A, Verness D. Detection and management of an implantable cardioverter defibrillator lead failure: incidence and clinical implications. J Am Coll Cardiol. 2003;41:73-80.
4. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, Stoner S, Baddour LM. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007;49:1851-1859.
5. Alter P, Waldhans S, Plachta E, Moosdorf R, Grimm W. Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. Pacing Clin Electrophysiol. 2005;28:926-932.
6. Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, Theuns D, Park RE, Wright DJ, Connelly DT, Fynn SP, Murgatroyd FD, Sperzel J, Neuzner J, Spitzer SG, Ardashev AV, Oduro A, Boersma L, Maass AH, Van Gelder IC, Wilde AA, van Dessel PF, Knops RE, Barr CS, Lupo P, Cappato R, Grace AA. An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med. 2010;363:36-44.
7. Dabiri Abkenari L, Theuns DA, Valk SD, Van Belle Y, de Groot NM, Haitsma D, Muskens-Heemskerk A, Szili-Torok T, Jordaens L. Clinical experience with a novel subcutaneous implantable defibrillator system in a single center. Clin Res Cardiol. 2011;100:737-744.
8. Jarman JW, Lascelles K, Wong T, Markides V, Clague JR, Till J. Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults: cause for caution. Eur Heart J. 2012;33:1351-1359.
9. Gold MR, Shih HT, Herre J, Breiter D, Zhang Y, Schwartz M; Low Energy Safety Study Investigators. Comparison of defibrillation efficacy and survival associated with right versus left pectoral placement for implantable defibrillators. Am J Cardiol. 2007;100:243-246.
10. Yasuda M, Nakazato Y, Sasaki A, Kawano Y, Nakazato K, Tokano T, Daida H. Ventricular fibrillation refractory to ICD therapy. Intern Med. 2005;44:829-831.
11. Maagh P, Trappe HJ, Meissner A. Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port. Europace. 2007;9:1161-1162.
12. Veltmann C, Borggrefe M, Schimpf R, Wolpert C. Fatal inappropriate ICD shock. J Cardiovasc Electrophysiol. 2007;18:326-328.
13. Margos PN, Schomburg R, Kynast J, Khattab AA, Richardt G. Termination of ventricular tachycardia with antitachycardia pacing after ineffective shock therapy in an ICD recipient with hypertrophic cardiomyopathy. Indian Pacing Electrophysiol J. 2009;9:64-70.
14. Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NA, 3rd, Spirito P. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med. 2000;342:365-373.
15. Brigadeau F, Kouakam C, Klug D, Marquié C, Duhamel A, Mizon-Gérard F, Lacroix D, Kacet S. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators. Eur Heart J. 2006;27:700-707.
16. Papaioannou GI, Kluger J. Ineffective ICD therapy due to excessive alcohol and exercise. Pacing Clin Electrophysiol. 2002;25:1144-1145.
17. Watanabe H, Chinushi M, Sugiura H, Washizuka T, Komura S, Hosaka Y, Furushima H, Watanabe H, Hayashi J, Aizawa Y. Unsuccessful internal defibrillation in Brugada syndrome: focus on refractoriness and ventricular fibrillation cycle length. J Cardiovasc Electrophysiol. 2005;16:262-266.
18. Day JD, Olshansky B, Moore S, Brown S, Stolen KQ, Lerew DR; INTRINSIC RV Study Investigators. High defibrillation energy requirements are encountered rarely with modern dual-chamber implantable cardioverter-defibrillator systems. Europace. 2008;10:347-350.